Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06727071 · ClinicalTrials.gov registry record · NA
Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes
A NA study, sponsored by University of California, San Diego.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06727071: Clinical Trial NA study, sponsored by University of California, San Diego.
NCT06727071 is a NA study that has not yet begun recruiting, run by University of California, San Diego. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06727071, a NA study, has not yet begun recruiting, sponsored by University of California, San Diego.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a single-site study using wearable sensor technology (CGM and smartwatch) to better explain low blood sugars in patients living with type 1 diabetes. Up to 20 participants with T1D will wear a continuous glucose monitor (CGM) and a smartwatch to collect information about hypoglycemia (low blood sugar), heart rate variability (HRV), and sleep for 4 weeks. The main goal is to create a hypoglycemia risk score using wearable sensor metrics that can be easily applied to all patients with T1D to identify those at greater risk of hypoglycemia.
Primary Outcome
The change in epinephrine from the start of the clamp to the end as measured in pg/mL.
Interventions
- PROCEDURE Hyperglycemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What is known before NCT06727071 opens enrollment
NCT06727071 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Hyperglycemic clamp is the first listed.
NCT06727071 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06727071 about?
NCT06727071 is a clinical study titled "Using Wearable Sensors To Understand Low Blood Sugar in Type 1 Diabetes". This is a single-site study using wearable sensor technology (CGM and smartwatch) to better explain low blood sugars in patients living with type 1 diabetes. Up to 20 participants with T1D will wear a continuous glucose monitor (CGM) and a smartwatch to collect information about hypoglycemia (low b...
What is the current status of trial NCT06727071?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-01. Estimated completion is 2026-06-30.
What interventions are being tested in trial NCT06727071?
The interventions under investigation include: Hyperglycemic clamp (PROCEDURE).
Who is sponsoring clinical trial NCT06727071?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06727071's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI